Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...

This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...

Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...

The treatment involves inserting a tiny implant thinner than human hair under the retina. Patients then have to wear glasses ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

AI translates electrical signals to the brain to help restore reading vision to treat a common form of blindness that was ...

CINCINNATI—Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver ...

Novo Nordisk is set to buy a blood disease drug from Omeros for up to $2.1 billion. Bristol Myers Squibb acquired Orbital Therapeutics for $1.5 billion. Boehringer Ingelheim offered up to $991 million ...